Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease

Objective: Currently there are no disease-specific approved therapies for non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH); however, several treatments are under development. This study aimed to estimate the cost-effectiveness of hypothetical innovative therapies compared wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Michal Pochopien (Author), Jakub Wladyslaw Dziedzic (Author), Samuel Aballea (Author), Emilie Clay (Author), Iwona Zerda (Author), Mondher Toumi (Author), Borislav Borissov (Author)
Format: Book
Published: Taylor & Francis Group, 2024-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items